Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2008
07/09/2008EP1941883A1 Use of sodium blockers for an early therapy of obstructive lung diseases
07/09/2008EP1940795A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands
07/09/2008EP1940415A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
07/09/2008EP1940409A1 Novel pharmaceutical combinations for the treatment of respiratory disorders
07/09/2008EP1940392A2 Combination of the pde4 inhibitor and a tetrahydrobiopterin derivative
07/09/2008EP1940372A1 Novel aromatic compounds and their use in medical applications
07/09/2008EP1572648B1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
07/09/2008EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus
07/09/2008EP1530464B1 Aerosol formulation for inhalation containing an anticholinergic agent
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
07/09/2008EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
07/09/2008CN101218209A Benzimidazole derivatives for treatment of inflammatory diseases
07/09/2008CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2
07/09/2008CN101215544A Inflammation-inhibiting compounds
07/09/2008CN101214332A Composition for treating asthmatic bronchitis and bronchial asthma and preparation thereof
07/09/2008CN101214301A Qingkailing freeze-drying preparations and preparation thereof
07/09/2008CN101214297A Medicament for treating cough and preparation thereof
07/09/2008CN101214295A Medicament for treating chicken infectivity laryngotracheitis
07/09/2008CN101214269A Method for extracting and concentrating total flavones of ilex hainanensis
07/09/2008CN101214268A Chinses hirsutella hepialid sinensis mixed powder and preparation method
07/09/2008CN101214265A Chinese cephalosporin cordyceps sinensis mixed powder and preparation method
07/09/2008CN101214255A Syringopicroside dropping pills and preparation technique thereof
07/09/2008CN101214246A Palmatine nano particle preparations and preparation thereof
07/09/2008CN101214245A Composition containing ciclacillin or its derivatives and preparation thereof
07/09/2008CN101214227A Ambroxol hydrochloride dry powder inhalant and preparation thereof
07/09/2008CN101214222A Injection for treating cow escherichia coli mastitis and pig bacterial respiratory tract infection and preparation thereof
07/09/2008CN101214221A Pharmaceutical formulation for treating rhinitis and sinusitis
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/09/2008CN100400080C Compositions for treating and/or preventing pollinosis
07/09/2008CN100400056C Chinese medicinal preparation for treating lung fibrosis
07/09/2008CN100400046C Remedies for lung cancer
07/08/2008US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/08/2008US7396836 Pyrimidine compound and medicinal composition thereof
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester
07/08/2008US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
07/08/2008US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
07/08/2008US7396663 Isolated polynucleotide encoding a G-protein coupled receptor
07/08/2008US7396546 Anti-microbial compositions and methods of using same
07/08/2008CA2533061C Combinations comprising antimuscarinic agents and beta-adrenergic agonists
07/08/2008CA2445620C Tetracyclic compounds as pde5-inhibitors
07/08/2008CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
07/08/2008CA2432131C Pyrazole compounds useful as protein kinase inhibitors
07/08/2008CA2422819C Food supplement
07/08/2008CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
07/08/2008CA2333154C Microemulsion preconcentrates containing a piperidine substance p antagonist
07/08/2008CA2327336C Aerosol composition
07/08/2008CA2251656C Pharmaceutical compositions containing tyloxapol for administration to the respiratory tract
07/08/2008CA2200324C 4a-aryldecahydroisoquinoline compounds and medicinal use of the same
07/03/2008WO2008079687A1 Novel compounds as cannabinoid receptor ligands and uses thereof
07/03/2008WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/03/2008WO2008079312A2 Compositions for treatment of nasal congestion
07/03/2008WO2008079257A2 Methods for treating nasal congestion in pediatric patients
07/03/2008WO2008079256A2 Methods for treating nasal congestion in hypertensive or diabetic patients
07/03/2008WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
07/03/2008WO2008078730A1 Preparation for transnasal application
07/03/2008WO2008078069A1 Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor
07/03/2008WO2008077772A2 Combination of a retinoid and a platinum anticancer agent
07/03/2008WO2008077554A1 Cycloalkylamine substituted isoquinoline derivatives
07/03/2008WO2008077553A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
07/03/2008WO2008077550A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
07/03/2008WO2008041184A3 Muscarinic receptor antagonists
07/03/2008US20080161577 Muscarinic receptor antagonists; longer duration of action; side effect reduction; high potency; chronic obstructive pulmonary disease; asthma; inhalation; 2-[(S)-1-(8-Methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide
07/03/2008US20080161409 Compositions for treatement of croup and methods of administering same
07/03/2008US20080161400 Use of forms of propofol for treating diseases associated with oxidative stress
07/03/2008US20080161393 e.g. 1-{[( alpha -isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid; migraine, fibromyalgia, amyotrophic lateral sclerosis, irritable bowel syndrome, social phobia, Parkinson's disease, asthma, cough, or chronic obstructive pulmonary disease; sustained release
07/03/2008US20080161354 Stable s-nitrosothiols, method of synthesis and use
07/03/2008US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer
07/03/2008US20080161339 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors
07/03/2008US20080161334 Macrolides
07/03/2008US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same
07/03/2008US20080161297 Rho kinase inhibitors
07/03/2008US20080161290 Serine hydrolase inhibitors
07/03/2008US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use
07/03/2008US20080161231 Methods and compositions for promoting organ development
07/03/2008US20080160098 Use of simple amino acids to form porous particles
07/03/2008US20080160092 Use of simple amino acids to form porous particles
07/03/2008US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response
07/03/2008US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas
07/03/2008US20080159964 As polymer conjugates; reduced side effects; inhalation formulations and kits
07/03/2008US20080159962 administering Angiotensin Converting enzyme 2 (ACE2) for treating infection with acute respiratory Syndrome (SARS) Coronavirus; including AT1-inhibitor, AT2-agonist, a bradykinin receptor inhibitor, a renin inhibitor and/or an ACE inhibitor
07/03/2008CA2673920A1 Cycloalkylamine substituted isoquinoline derivatives
07/03/2008CA2673919A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
07/03/2008CA2673916A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
07/03/2008CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/03/2008CA2668159A1 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1939202A1 Novel adenine compound
07/02/2008EP1939201A1 Novel adenine compound
07/02/2008EP1939200A1 Novel adenine compound
07/02/2008EP1939199A1 Novel adenine compound
07/02/2008EP1939198A1 Novel adenine compound
07/02/2008EP1939194A1 Bicyclic aromatic substituted pyridone derivative
07/02/2008EP1939183A1 Novel nitrogenated heterocyclic compound
07/02/2008EP1939175A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
07/02/2008EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression
07/02/2008EP1938822A1 Combination therapy for the treatment of airways disease
07/02/2008EP1938817A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion